This review summarizes VTE risk factors, assessment tools, prophylaxis, and diagnostic biomarkers in hospitalized surgical patients.
Supports VTE risk stratification and prophylaxis in surgical inpatients; leaves open prospective biomarker validation.
Venous thromboembolism is a common and potentially preventable disease in hospitalized patients. Risk assessment and prophylaxis is also an important quality of care measure. Herein, we discuss the negative impact of VTE on surgical patients, review the risk factors for VTE, the risk assessment tools, available prophylaxis, and then summarize the use of biomarkers for VTE diagnosis.
No takes yet. Share an insight, caveat, or question.
Henke et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: